---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-214188"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:17:15.582311+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Aligos Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on Sept 3, 2024 confirming compliance with Minimum Bid Price Requirement.
- Previous deficiency letter was dated Sept 5, 2023; stock had closed below $1.00 for 30 consecutive days.
- Compliance achieved under Nasdaq Listing Rules 5450(a)(1) and 5550(a)(2); matter is closed.
- No additional financial or operational details provided in the filing.

## SEC filing metadata
- accession: 0001193125-24-214188
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312524214188/0001193125-24-214188-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524214188/d857897d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-214188
- JSON: https://secwatch.observer/filing/0001193125-24-214188.json
- Plain text: https://secwatch.observer/filing/0001193125-24-214188.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.